HEALTH

McNeil adds Zyrtec Dissolve Tabs to best-selling allergy brand

BY Michael Johnsen

FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Wednesday introduced a new form to the Zyrtec portfolio of allergy-relief products — an oral, dissolvable tablet. Delivering the same effective 24-hour relief, Zyrtec Dissolve Tabs are now available at all major retailers and pharmacies.

Zyrtec, the best-selling brand within the cold-allergy-sinus tablet category, generated $317.3 million for the 52 weeks ended Dec. 29, up 1.8% across total U.S. multi-outlet, according to IRI data. 

"Expanding the Zyrtec portfolio to include a dissolvable tab provides the brand an opportunity to reach children as well as the adult consumer who is sometimes caught off guard by their allergy symptoms," stated Colleen Sellers, group brand director, allergy at McNeil Consumer Healthcare. "Zyrtec Dissolve Tabs are ideal for ‘on the go’ situations because they can be taken anytime, anywhere without water."

The launch of the Zyrtec Dissolve Tabs will come to life through various marketing channels, including dedicated digital, television and radio advertising as well as retail activations. The advertising campaign will begin mid-March and will run nationally as well as in strategic regional markets, McNeil reported. 

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Sam’s Club to host free allergy and health screenings

BY Michael Johnsen

BENTONVILLE, ARK. — On March 8, Sam’s Club will host free allergy and health screenings to members and visitors at Sam’s Club locations with a pharmacy — 584 locations — to ease management of allergies this season, the club operator announced Wednesday.

“Seasonal allergies can be the source of distress and discomfort to millions, particularly as flowers and trees bloom,” stated Jill Turner-Mitchael, SVP Sam’s Club Health and Wellness. “Our screening program helps Sam’s Club pharmacy patients pinpoint allergy causes, prevent symptoms and actively maintain daily wellness at an amazing savings.”

While supplies last, free in-club health screenings are valued at up to $200 and include:

  • Allergy IgE screening: An elevated level of total Immunoglobin E may indicate an allergy or parasitic infection is present. This test is useful in predicting positive results of allergen-specific tests for the common allergens such as pollen, dust or pet dander, and certain parasitic infections;
  • Blood pressure;
  • Body mass index; and
  • Vision, where allowed by state law.

In addition to allergy screenings, Sam’s Club pharmacies offer year-round immunizations for adults ages 18 and above. Licensed pharmacists can administer walk-in flu shots and nine important immunizations recommended to help protect against serious diseases like pneumonia, shingles and whooping cough.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Consumer trust intact as McNeil brands like Tylenol return back to shelf

BY Michael Johnsen

NEW BRUNSWICK, N.J. — McNeil Consumer Healthcare has about 75% of its consumer brands back on shelf, Dominic Caruso, Johnson & Johnson VP finance and CFO, told attendees of the Cowen and Company Health Care Conference on Tuesday. 

"We are schedule to restore our reliable supply of products in the OTC marketplace," he said. "You should start seeing more Tylenol Children’s advertising on TV. That’s a good sign. It means we are confident that the products now are not only back on the shelves but they are back on the shelves in a reliable manner."

And consumers still trust McNeil’s venerable brand names, such as Tylenol. "The various trusts … remain strong," Caruso said. "We’re communicating with consumers as these products are back on the shelf. And I’m happy to tell you that once they are back on the shelf … consumers are readopting these products as a main stay in their regimen."

The proof of Tylenol’s successful return to market is in the sales. For the 52 weeks ended Dec. 29, 2013, sales of Tylenol internal analgesic tablets were up 39.9% to $200.1 million across U.S. multi-outlet, according to IRI. McNeil is successfully converting consumers back to brand — sales of private label internal analgesic tablets totaled almost $1.3 billion, but were down 3.8%, in part because of the return of Tylenol. 

Consumer sales accounts for approximately 20% of J&J sales overall, Caruso said, with the division generating nearly $15 billion in sales and growing at a 3% clip. "We have in fact restored reliable supplier products in the market," he said. "We have really 12 major brands that we’re investing behind which we think are the major growth engines in this business."

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?